Nitroglycerin (Lingual spray)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Nitroglycerin (Lingual spray) is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
There is limited information regarding Nitroglycerin (Lingual spray) FDA-Labeled Indications and Dosage (Adult) in the drug label.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Nitroglycerin (Lingual spray) in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Nitroglycerin (Lingual spray) in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Nitroglycerin (Lingual spray) FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Nitroglycerin (Lingual spray) in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Nitroglycerin (Lingual spray) in pediatric patients.
Contraindications
4.1 PDE-5-Inhibitors and sGC-Stimulators Do not use Nitrolingual Pumpspray in patients who are taking PDE-5 inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil. Concomitant use can cause severe hypotension, syncope, or myocardial ischemia [see DRUG INTERACTIONS (7.1)].
Do not use Nitrolingual Pumpspray in patients who are taking the soluble guanylate cyclase (sGC) stimulator riociguat. Concomitant use can cause hypotension.
4.2 Severe Anemia Nitrolingual Pumpspray is contraindicated in patients with severe anemia (large doses of nitroglycerin may cause oxidation of hemoglobin to methemoglobin and could exacerbate anemia).
4.3 Increased Intracranial Pressure Nitrolingual Pumpspray may precipitate or aggravate increased intracranial pressure and thus should not be used in patients with possible increased intracranial pressure (e. g. cerebral hemorrhage or traumatic brain injury).
4.4 Hypersensitivity Nitrolingual Pumpspray is contraindicated in patients who are allergic to nitroglycerin, other nitrates or nitrites or any excipient.
4.5 Circulatory Failure and Shock Nitrolingual Pumpspray is contraindicated in patients with acute circulatory failure or shock.
Warnings
There is limited information regarding Nitroglycerin (Lingual spray) Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trials Experience of Nitroglycerin (Lingual spray) in the drug label.
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Nitroglycerin (Lingual spray) in the drug label.
Drug Interactions
There is limited information regarding Nitroglycerin (Lingual spray) Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Nitroglycerin (Lingual spray) in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Nitroglycerin (Lingual spray) in women who are pregnant.
Labor and Delivery
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) with respect to specific gender populations.
Race
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance on the use of Nitroglycerin (Lingual spray) in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Nitroglycerin (Lingual spray) Administration in the drug label.
Monitoring
There is limited information regarding Monitoring of Nitroglycerin (Lingual spray) in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Nitroglycerin (Lingual spray) and IV administrations.
Overdosage
There is limited information regarding Nitroglycerin (Lingual spray) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Nitroglycerin (Lingual spray) Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Nitroglycerin (Lingual spray) Mechanism of Action in the drug label.
Structure
There is limited information regarding Nitroglycerin (Lingual spray) Structure in the drug label.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Nitroglycerin (Lingual spray) in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Nitroglycerin (Lingual spray) in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Nitroglycerin (Lingual spray) in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Nitroglycerin (Lingual spray) in the drug label.
How Supplied
There is limited information regarding Nitroglycerin (Lingual spray) How Supplied in the drug label.
Storage
There is limited information regarding Nitroglycerin (Lingual spray) Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Nitroglycerin (Lingual spray) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Nitroglycerin (Lingual spray) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Nitroglycerin (Lingual spray) in the drug label.
Precautions with Alcohol
Alcohol-Nitroglycerin (Lingual spray) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
®
Look-Alike Drug Names
A® — B®
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.